Alan Katz

Alan Katz was diagnosed with Acute Myeloid Leukemia with a FLT3 mutation in November 2020 and had a bone marrow transplant in February 2021. Alan relapsed in May 2021 and had a Donor Lymphocyte Infusion in June 2021. He was able to get back into remission. He has been taking Xospata since his relapse and has continued to get better ever since. He has gone back to work part time and spends time taking care of his grandchildren. He also volunteers for various blood cancer advocacy groups.